| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Single-Cell Analysis | 6 | 2024 | 155 | 2.050 |
Why?
|
| B-Lymphocytes | 4 | 2024 | 740 | 1.450 |
Why?
|
| Sequence Analysis, RNA | 5 | 2024 | 240 | 1.030 |
Why?
|
| Tumor Microenvironment | 2 | 2019 | 476 | 0.970 |
Why?
|
| Immunoglobulin Class Switching | 2 | 2024 | 38 | 0.970 |
Why?
|
| Cell Lineage | 1 | 2024 | 292 | 0.850 |
Why?
|
| Supervised Machine Learning | 1 | 2021 | 10 | 0.760 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2019 | 135 | 0.730 |
Why?
|
| Immunotherapy | 4 | 2022 | 688 | 0.720 |
Why?
|
| Immune System | 2 | 2017 | 97 | 0.630 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 167 | 0.620 |
Why?
|
| Genomics | 5 | 2022 | 774 | 0.610 |
Why?
|
| Immunity, Innate | 2 | 2019 | 433 | 0.610 |
Why?
|
| MicroRNAs | 5 | 2018 | 555 | 0.570 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2018 | 117 | 0.560 |
Why?
|
| Allergy and Immunology | 1 | 2017 | 13 | 0.560 |
Why?
|
| Gene Expression Profiling | 6 | 2019 | 1445 | 0.550 |
Why?
|
| Polymorphism, Genetic | 2 | 2019 | 825 | 0.540 |
Why?
|
| Algorithms | 1 | 2024 | 1896 | 0.530 |
Why?
|
| Biomarkers, Tumor | 4 | 2022 | 1540 | 0.510 |
Why?
|
| Gene Expression | 4 | 2021 | 1309 | 0.500 |
Why?
|
| Precision Medicine | 5 | 2022 | 409 | 0.470 |
Why?
|
| Gene Expression Regulation | 7 | 2021 | 1982 | 0.460 |
Why?
|
| Computational Biology | 5 | 2021 | 549 | 0.450 |
Why?
|
| Software | 2 | 2018 | 666 | 0.440 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 1125 | 0.430 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2024 | 488 | 0.410 |
Why?
|
| Neoplasms | 4 | 2021 | 3053 | 0.400 |
Why?
|
| Mice | 18 | 2024 | 11828 | 0.350 |
Why?
|
| Autoimmunity | 3 | 2024 | 169 | 0.350 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 2364 | 0.330 |
Why?
|
| Androgens | 2 | 2024 | 175 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 7 | 2024 | 3237 | 0.320 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2024 | 2354 | 0.300 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 2021 | 165 | 0.290 |
Why?
|
| Transfection | 1 | 2009 | 909 | 0.290 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 557 | 0.290 |
Why?
|
| Dendritic Cells | 3 | 2017 | 451 | 0.280 |
Why?
|
| Animals | 20 | 2024 | 27476 | 0.280 |
Why?
|
| Genetic Variation | 3 | 2024 | 1380 | 0.270 |
Why?
|
| Humans | 27 | 2024 | 89567 | 0.260 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2018 | 135 | 0.250 |
Why?
|
| Transcriptome | 3 | 2021 | 654 | 0.240 |
Why?
|
| Interferon Regulatory Factors | 3 | 2017 | 69 | 0.240 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2024 | 9 | 0.240 |
Why?
|
| Immunoglobulin G | 3 | 2021 | 469 | 0.240 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2024 | 34 | 0.230 |
Why?
|
| Immune Tolerance | 2 | 2017 | 341 | 0.230 |
Why?
|
| Genome-Wide Association Study | 5 | 2024 | 1685 | 0.230 |
Why?
|
| Receptors, Androgen | 1 | 2024 | 119 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2023 | 565 | 0.220 |
Why?
|
| Interleukin-4 | 2 | 2021 | 129 | 0.220 |
Why?
|
| Cell Communication | 1 | 2024 | 200 | 0.210 |
Why?
|
| Population Health | 1 | 2023 | 33 | 0.210 |
Why?
|
| Linkage Disequilibrium | 1 | 2024 | 477 | 0.210 |
Why?
|
| Transcription, Genetic | 2 | 2018 | 1158 | 0.210 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 2 | 2021 | 45 | 0.210 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2024 | 212 | 0.200 |
Why?
|
| Retroviridae | 1 | 2022 | 79 | 0.200 |
Why?
|
| Open Reading Frames | 1 | 2021 | 121 | 0.190 |
Why?
|
| Receptors, Cytokine | 1 | 2021 | 28 | 0.190 |
Why?
|
| STAT6 Transcription Factor | 1 | 2021 | 28 | 0.190 |
Why?
|
| Signal Transduction | 3 | 2024 | 3395 | 0.190 |
Why?
|
| Exome | 1 | 2021 | 131 | 0.190 |
Why?
|
| Databases, Nucleic Acid | 1 | 2021 | 41 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2024 | 2411 | 0.190 |
Why?
|
| Organoids | 1 | 2021 | 63 | 0.180 |
Why?
|
| Models, Immunological | 1 | 2021 | 81 | 0.180 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2021 | 42 | 0.180 |
Why?
|
| Allografts | 1 | 2021 | 183 | 0.180 |
Why?
|
| Immunity, Humoral | 2 | 2018 | 66 | 0.180 |
Why?
|
| Leukemia | 1 | 2022 | 322 | 0.180 |
Why?
|
| Lipids | 1 | 2021 | 275 | 0.170 |
Why?
|
| Gene Regulatory Networks | 2 | 2014 | 309 | 0.170 |
Why?
|
| Defensins | 1 | 2019 | 5 | 0.170 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 294 | 0.170 |
Why?
|
| Coronary Artery Disease | 1 | 2024 | 364 | 0.170 |
Why?
|
| Computer Simulation | 2 | 2021 | 1101 | 0.170 |
Why?
|
| Cell Differentiation | 5 | 2018 | 1529 | 0.170 |
Why?
|
| T-Lymphocytes | 2 | 2024 | 1221 | 0.170 |
Why?
|
| Antigen Presentation | 3 | 2017 | 215 | 0.170 |
Why?
|
| Major Histocompatibility Complex | 1 | 2019 | 84 | 0.170 |
Why?
|
| Bacteria | 2 | 2022 | 481 | 0.160 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 160 | 0.160 |
Why?
|
| Recombination, Genetic | 1 | 2021 | 446 | 0.160 |
Why?
|
| Models, Biological | 4 | 2021 | 1762 | 0.160 |
Why?
|
| Phylogeny | 1 | 2024 | 1191 | 0.160 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 142 | 0.160 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 250 | 0.160 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 597 | 0.150 |
Why?
|
| Plasma Cells | 1 | 2018 | 84 | 0.150 |
Why?
|
| Protein Interaction Mapping | 1 | 2018 | 81 | 0.150 |
Why?
|
| Germinal Center | 1 | 2018 | 55 | 0.150 |
Why?
|
| Rauscher Virus | 1 | 2017 | 8 | 0.150 |
Why?
|
| HLA-D Antigens | 1 | 2017 | 20 | 0.150 |
Why?
|
| Influenza Vaccines | 1 | 2018 | 150 | 0.140 |
Why?
|
| Genome | 1 | 2020 | 391 | 0.140 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2017 | 64 | 0.140 |
Why?
|
| Retroviridae Infections | 1 | 2017 | 48 | 0.140 |
Why?
|
| Microbiota | 1 | 2023 | 406 | 0.140 |
Why?
|
| Immunologic Techniques | 1 | 2017 | 26 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 1090 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2017 | 312 | 0.140 |
Why?
|
| Lymphocyte Activation | 5 | 2024 | 754 | 0.140 |
Why?
|
| Antibodies, Neutralizing | 1 | 2017 | 123 | 0.140 |
Why?
|
| Th2 Cells | 2 | 2017 | 147 | 0.140 |
Why?
|
| Mice, Inbred NOD | 3 | 2024 | 198 | 0.140 |
Why?
|
| Vaccination | 1 | 2018 | 277 | 0.140 |
Why?
|
| Intestines | 1 | 2019 | 416 | 0.130 |
Why?
|
| Hypertension | 1 | 2022 | 745 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 868 | 0.130 |
Why?
|
| Inflammation | 1 | 2021 | 975 | 0.130 |
Why?
|
| Graft Rejection | 1 | 2021 | 1072 | 0.130 |
Why?
|
| RNA | 1 | 2019 | 581 | 0.120 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 805 | 0.120 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2014 | 13 | 0.120 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2014 | 8 | 0.120 |
Why?
|
| Mice, Transgenic | 5 | 2018 | 1576 | 0.120 |
Why?
|
| Kidney Transplantation | 1 | 2021 | 854 | 0.120 |
Why?
|
| fas Receptor | 1 | 2014 | 77 | 0.110 |
Why?
|
| Male | 10 | 2024 | 42464 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 1281 | 0.110 |
Why?
|
| Immunity | 1 | 2014 | 141 | 0.110 |
Why?
|
| Mice, Knockout | 4 | 2024 | 2012 | 0.110 |
Why?
|
| Proteins | 1 | 2018 | 786 | 0.110 |
Why?
|
| Female | 10 | 2024 | 46371 | 0.110 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 516 | 0.100 |
Why?
|
| Transcription Factor AP-1 | 1 | 2012 | 65 | 0.100 |
Why?
|
| Immunomodulation | 1 | 2012 | 57 | 0.100 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2012 | 46 | 0.100 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2013 | 319 | 0.100 |
Why?
|
| Whole Genome Sequencing | 2 | 2024 | 101 | 0.100 |
Why?
|
| Th17 Cells | 1 | 2012 | 85 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2013 | 184 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 294 | 0.090 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 250 | 0.090 |
Why?
|
| Transcription Factors | 3 | 2014 | 1662 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 2 | 2021 | 71 | 0.090 |
Why?
|
| Multifactorial Inheritance | 2 | 2023 | 173 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 153 | 0.090 |
Why?
|
| Phenotype | 3 | 2021 | 2447 | 0.090 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 54 | 0.090 |
Why?
|
| Models, Genetic | 2 | 2020 | 947 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2012 | 2582 | 0.090 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2009 | 3 | 0.080 |
Why?
|
| Genes, cdc | 1 | 2009 | 5 | 0.080 |
Why?
|
| Glioblastoma | 1 | 2012 | 265 | 0.080 |
Why?
|
| Cell Line | 2 | 2014 | 2494 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 305 | 0.080 |
Why?
|
| Autoantibodies | 2 | 2021 | 268 | 0.080 |
Why?
|
| Blood Pressure | 2 | 2023 | 902 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2024 | 1862 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 247 | 0.080 |
Why?
|
| Protein Binding | 3 | 2018 | 1491 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 1243 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2009 | 725 | 0.070 |
Why?
|
| Antibodies, Viral | 2 | 2018 | 311 | 0.070 |
Why?
|
| Mice, Inbred Strains | 2 | 2017 | 308 | 0.060 |
Why?
|
| Gene Frequency | 1 | 2024 | 687 | 0.050 |
Why?
|
| Proteolysis | 1 | 2023 | 111 | 0.050 |
Why?
|
| Glutens | 1 | 2023 | 84 | 0.050 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 25 | 0.050 |
Why?
|
| Gene Ontology | 1 | 2021 | 34 | 0.050 |
Why?
|
| Palatine Tonsil | 1 | 2021 | 30 | 0.050 |
Why?
|
| Loss of Heterozygosity | 1 | 2021 | 86 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 78 | 0.050 |
Why?
|
| Fluorescence | 1 | 2021 | 103 | 0.050 |
Why?
|
| Symbiosis | 1 | 2022 | 127 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2021 | 1668 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2021 | 116 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2021 | 201 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2022 | 213 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2021 | 269 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 885 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2021 | 370 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 201 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 693 | 0.040 |
Why?
|
| HLA Antigens | 1 | 2021 | 227 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2021 | 312 | 0.040 |
Why?
|
| Diet | 1 | 2023 | 443 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2020 | 226 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2021 | 995 | 0.040 |
Why?
|
| Genetics, Population | 1 | 2021 | 407 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2018 | 83 | 0.040 |
Why?
|
| CD40 Antigens | 1 | 2018 | 44 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 77 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2013 | 2884 | 0.040 |
Why?
|
| Alleles | 1 | 2021 | 1136 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2021 | 837 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 336 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2018 | 276 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 279 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 262 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 2384 | 0.040 |
Why?
|
| Hepatitis B | 1 | 2017 | 76 | 0.030 |
Why?
|
| Liver | 1 | 2021 | 1208 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2017 | 515 | 0.030 |
Why?
|
| Kidney | 1 | 2021 | 1147 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2017 | 166 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2012 | 2021 | 0.030 |
Why?
|
| Hepatitis C | 1 | 2017 | 174 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2021 | 1227 | 0.030 |
Why?
|
| Vero Cells | 1 | 2014 | 103 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2014 | 49 | 0.030 |
Why?
|
| Nippostrongylus | 1 | 2013 | 4 | 0.030 |
Why?
|
| Strongylida Infections | 1 | 2013 | 7 | 0.030 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2013 | 12 | 0.030 |
Why?
|
| Interleukin-33 | 1 | 2013 | 26 | 0.030 |
Why?
|
| Castration | 1 | 2013 | 37 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 25996 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 2013 | 36 | 0.030 |
Why?
|
| GATA3 Transcription Factor | 1 | 2013 | 48 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2013 | 38 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2017 | 465 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2013 | 127 | 0.030 |
Why?
|
| Transgenes | 1 | 2013 | 185 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2014 | 154 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 1180 | 0.030 |
Why?
|
| Interleukins | 1 | 2013 | 131 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2014 | 341 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 806 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2013 | 105 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 309 | 0.030 |
Why?
|
| Metagenome | 1 | 2013 | 105 | 0.030 |
Why?
|
| Risk Factors | 1 | 2023 | 5523 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 137 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 237 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 689 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 983 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 191 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2012 | 58 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2013 | 449 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2013 | 468 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 1120 | 0.020 |
Why?
|
| Luciferases | 1 | 2011 | 128 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2013 | 327 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 303 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 952 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 323 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 590 | 0.020 |
Why?
|
| Macrophages | 1 | 2013 | 578 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 793 | 0.020 |
Why?
|
| United States | 1 | 2021 | 7041 | 0.020 |
Why?
|
| Survival Rate | 1 | 2011 | 1887 | 0.020 |
Why?
|
| Lung | 1 | 2013 | 1273 | 0.020 |
Why?
|
| Genome, Human | 1 | 2012 | 791 | 0.020 |
Why?
|
| Mutation | 1 | 2017 | 4159 | 0.020 |
Why?
|
| Apoptosis | 1 | 2011 | 1717 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 3174 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 3754 | 0.010 |
Why?
|
| Child | 1 | 2011 | 7214 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 6362 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 9299 | 0.010 |
Why?
|
| Adult | 1 | 2011 | 26684 | 0.010 |
Why?
|